Grail, Inc. (NASDAQ:GRAL) President Joshua J. Ofman Sells 2,109 Shares

Grail, Inc. (NASDAQ:GRAL) President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the transaction, the president now directly owns 559,673 shares in the company, valued at $17,461,797.60. This represents a 0.38 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Grail Stock Performance

Grail stock opened at $30.85 on Thursday. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The company’s 50-day moving average price is $31.42 and its 200-day moving average price is $21.15.

Grail (NASDAQ:GRAL) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analysts’ expectations of $35.33 million. As a group, equities analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.

Institutional Investors Weigh In On Grail

Institutional investors have recently made changes to their positions in the company. Crcm LP purchased a new stake in Grail in the 4th quarter worth about $65,061,000. Sessa Capital IM L.P. purchased a new position in Grail in the 4th quarter worth about $53,550,000. Primecap Management Co. CA bought a new stake in Grail during the 4th quarter valued at about $37,118,000. Baker BROS. Advisors LP bought a new stake in Grail during the 4th quarter valued at about $29,098,000. Finally, Vanguard Group Inc. purchased a new stake in shares of Grail in the 4th quarter worth $25,902,000.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on GRAL shares. Morgan Stanley began coverage on shares of Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price for the company. Wolfe Research assumed coverage on Grail in a research note on Friday, November 15th. They set a “peer perform” rating for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.